PLAVIX 300 mg, film-coated tablet 30 tablets
Brand page: Plavix (clopidogrel) — all forms and strengths in France
Active ingredients: Clopidogrel bisulfate, Clopidogrel
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PLAVIX 300 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- 30 plaquette(s) thermoformée(s) aluminium de 1 comprimé(s)
- Marketing authorisation holder
- SANOFI WINTHROP INDUSTRIE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 2 Oct 2008
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60562855CIP75730192CIP133400957301927Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CLOPIDOGREL (HYDROGÉNOSULFATE DE)comprimé | — | SA |
| CLOPIDOGREL BASEcomprimé | 300 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The published catalog does not list other packages of similar medicines.